🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/11/1986 | 5,83 | 5,94 | 5,82 | 5,84 | +0,00% | 2,04% | 8.622.734 |
| 21/11/1986 | 5,62 | 5,84 | 5,62 | 5,84 | +4,13% | 4,01% | 12.718.109 |
| 20/11/1986 | 5,51 | 5,62 | 5,43 | 5,61 | +4,31% | 3,37% | 7.219.253 |
| 19/11/1986 | 5,38 | 5,47 | 5,33 | 5,38 | -2,99% | 2,59% | 6.951.384 |
| 18/11/1986 | 5,53 | 5,55 | 5,33 | 5,55 | +0,00% | 4,08% | 6.032.707 |
| 17/11/1986 | 5,54 | 5,57 | 5,52 | 5,55 | -0,36% | 0,84% | 3.944.462 |
| 14/11/1986 | 5,61 | 5,61 | 5,55 | 5,57 | -0,71% | 1,06% | 3.984.077 |
| 13/11/1986 | 5,67 | 5,71 | 5,60 | 5,61 | -1,28% | 1,87% | 4.834.843 |
| 12/11/1986 | 5,67 | 5,71 | 5,63 | 5,68 | -0,12% | 1,29% | 3.789.778 |
| 11/11/1986 | 5,67 | 5,73 | 5,67 | 5,69 | +0,23% | 0,93% | 2.386.296 |
| 10/11/1986 | 5,68 | 5,71 | 5,61 | 5,67 | -0,35% | 1,75% | 3.206.880 |
| 07/11/1986 | 5,74 | 5,76 | 5,65 | 5,69 | -1,04% | 1,85% | 4.295.333 |
| 06/11/1986 | 5,80 | 5,82 | 5,68 | 5,75 | -0,91% | 2,40% | 6.260.962 |
| 05/11/1986 | 5,78 | 5,87 | 5,78 | 5,80 | -0,45% | 1,61% | 7.432.416 |
| 04/11/1986 | 5,82 | 5,86 | 5,80 | 5,83 | +0,00% | 0,91% | 7.807.810 |
| 03/11/1986 | 5,78 | 5,85 | 5,76 | 5,83 | +1,27% | 1,49% | 5.664.859 |
| 31/10/1986 | 5,73 | 5,76 | 5,70 | 5,76 | -0,80% | 1,16% | 4.729.205 |
| 30/10/1986 | 5,80 | 5,83 | 5,78 | 5,80 | +1,62% | 0,80% | 16.736.141 |
| 29/10/1986 | 5,67 | 5,73 | 5,67 | 5,71 | +0,35% | 1,05% | 2.884.306 |
| 28/10/1986 | 5,74 | 5,75 | 5,67 | 5,69 | -0,12% | 1,27% | 3.112.560 |
| 27/10/1986 | 5,76 | 5,77 | 5,70 | 5,70 | -1,38% | 1,26% | 4.463.222 |
| 24/10/1986 | 5,81 | 5,83 | 5,75 | 5,78 | -0,46% | 1,37% | 4.942.368 |
| 23/10/1986 | 5,73 | 5,84 | 5,73 | 5,80 | +1,51% | 2,08% | 8.405.798 |
| 22/10/1986 | 5,69 | 5,75 | 5,66 | 5,72 | +0,82% | 1,63% | 5.702.587 |
| 21/10/1986 | 5,70 | 5,71 | 5,65 | 5,67 | -0,58% | 1,05% | 3.699.230 |
| 20/10/1986 | 5,74 | 5,74 | 5,65 | 5,71 | -1,49% | 1,62% | 4.723.546 |
| 17/10/1986 | 5,73 | 5,79 | 5,71 | 5,79 | +0,81% | 1,39% | 10.416.701 |
| 16/10/1986 | 5,69 | 5,76 | 5,66 | 5,75 | +1,52% | 1,75% | 9.788.530 |
| 15/10/1986 | 5,49 | 5,66 | 5,47 | 5,66 | +3,39% | 3,38% | 10.363.882 |
| 14/10/1986 | 5,45 | 5,49 | 5,44 | 5,47 | +0,98% | 0,85% | 6.238.325 |